Filing Details

Accession Number:
0001140361-15-040050
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-06 17:44:49
Reporting Period:
2015-10-30
Filing Date:
2015-11-06
Accepted Time:
2015-11-06 17:44:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1557533 Robert Jeffrey Ajer C/O Biomarin Pharmaceutical Inc.,
770 Lindaro St.
San Rafael CA 94901
Svp, Chief Commercial Of No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-10-30 26 $57.26 35,631 No 4 A Direct
Common Stock Disposition 2015-11-02 26 $117.56 35,605 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. The reporting person is reporting the purchase of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of May 1, 2015 to October 31, 2015.
  2. Transaction made pursuant to a Rule 10b5-1 trading plan executed on December May 11, 2015.
  3. Due to administrative oversight the reported transaction, which should have been filed 11/4/2015 is being reported late.
  4. All shares sold at same price.